A detailed history of Regent Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Regent Investment Management LLC holds 20,488 shares of ABBV stock, worth $3.69 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
20,488
Previous 20,588 0.49%
Holding current value
$3.69 Million
Previous $2.76 Million 19.83%
% of portfolio
0.89%
Previous 0.81%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$138.31 - $165.87 $13,831 - $16,587
-100 Reduced 0.49%
20,488 $3.31 Million
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $3,355 - $3,848
25 Added 0.12%
20,588 $2.76 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $125,784 - $159,913
-914 Reduced 4.26%
20,563 $3.15 Million
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $127,624 - $158,346
-967 Reduced 4.31%
21,477 $3.48 Million
Q4 2021

Jan 27, 2022

BUY
$107.43 - $135.93 $23,312 - $29,496
217 Added 0.98%
22,444 $3.04 Million
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $98,845 - $112,204
929 Added 4.36%
22,227 $2.4 Million
Q2 2021

Jul 16, 2021

SELL
$105.21 - $117.21 $25,250 - $28,130
-240 Reduced 1.11%
21,298 $2.4 Million
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $134,013 - $147,532
1,310 Added 6.48%
21,538 $2.33 Million
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $1.63 Million - $2.2 Million
20,228 New
20,228 $2.17 Million
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $1.77 Million - $2.08 Million
-20,620 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$73.37 - $98.18 $323,121 - $432,384
4,404 Added 27.16%
20,620 $2.03 Million
Q1 2020

Apr 17, 2020

SELL
$64.5 - $97.79 $52,567 - $79,698
-815 Reduced 4.79%
16,216 $1.24 Million
Q4 2019

Jan 30, 2020

SELL
$72.13 - $90.25 $182,849 - $228,783
-2,535 Reduced 12.96%
17,031 $1.51 Million
Q3 2019

Oct 17, 2019

SELL
$62.98 - $75.72 $82,818 - $99,571
-1,315 Reduced 6.3%
19,566 $1.48 Million
Q1 2019

Apr 22, 2019

SELL
$77.14 - $90.79 $58,626 - $69,000
-760 Reduced 3.51%
20,881 $1.68 Million
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $60,333 - $74,407
775 Added 3.71%
21,641 $2 Million
Q3 2018

Oct 22, 2018

BUY
$88.91 - $98.84 $668,158 - $742,782
7,515 Added 56.29%
20,866 $1.97 Million
Q2 2018

Jul 16, 2018

BUY
$89.78 - $106.23 $9,516 - $11,260
106 Added 0.8%
13,351 $1.24 Million
Q1 2018

Apr 24, 2018

BUY
$92.01 - $123.21 $9,201 - $12,321
100 Added 0.76%
13,245 $1.25 Million
Q4 2017

Jan 26, 2018

BUY
$89.56 - $98.21 $16,747 - $18,365
187 Added 1.44%
13,145 $1.27 Million
Q3 2017

Oct 12, 2017

BUY
$69.85 - $89.22 $905,116 - $1.16 Million
12,958
12,958 $1.15 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Regent Investment Management LLC Portfolio

Follow Regent Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regent Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regent Investment Management LLC with notifications on news.